Citations

Clear

371 citation(s) found for "Cho, B".

Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-β
Park, Laibaik , Zhou, Ping , Zhou, Joan, Pitstick, Rose, Previti, Mary Lou , Younkin, Linda H., Younkin, Steven G. , Nostrand, William E. Van , Anrather, Josef , Carlson, George A. , Iadecola, Costantino , Wang, Gang , Cho, Sunghee

Mayo Clinic

Proceedings of the National Academy of Sciences | March 8, 2011 | Volume: 108 | Issue: 12 | Pages: 5063-5068

10.1073/pnas.1015413108 | PMID 21383152 Get It

Increasing evidence indicates that cerebrovascular dysfunction plays a pathogenic role in Alzheimer's dementia (AD). Amyloid-β (Aβ), a peptide central to the pathogenesis of AD, has profound vascular effects mediated, for the most part, by reactive oxygen species produced by the enzyme NADPH oxidase. The mechanisms linking Aβ to NADPH oxidase-dependent vascular oxidative stress have not been identified, however. We report that the scavenger receptor CD36, a membrane glycoprotein that binds Aβ, is essential for the vascular oxidative stress and neurovascular dysfunction induced by Aβ 1–40 . Thus, topical application of Aβ 1–40 onto the somatosensory cortex attenuates the increase in cerebral blood flow elicited by neural activity or by endothelium-dependent vasodilators in WT mice but not in CD36-null mice (CD36 0/0 ). The cerebrovascular effects of infusion of Aβ 1–40 into cerebral arteries are not observed in mice pretreated with CD36 blocking antibodies or in CD36 0/0 mice. Furthermore, CD36 deficiency prevents the neurovascular dysfunction observed in transgenic mice overexpressing the Swedish mutation of the amyloid precursor protein Tg2576 despite elevated levels of brain Aβ 1–40 . CD36 is also required for the vascular oxidative stress induced by exogenous Aβ 1–40 or observed in Tg2576 mice. These observations establish CD36 as a key link between Aβ 1–40 and the NADPH oxidase-dependent vascular oxidative stress underlying the neurovascular dysfunction and suggest that CD36 is a potential therapeutical target to counteract the cerebrovascular dysfunction associated with Aβ.
Deep Brain Stimulation: Technology at the Cutting Edge
Shah, Rahul S. , Chang, Su-Youne , Min, Hoon‐Ki , Cho, Zang‐Hee , Blaha, Charles D. , Lee, Kendall H. , Min, Hoon-Ki Paul , Blaha, Charles

Mayo Clinic

Journal of Clinical Neurology | January 20, 2011 | Volume: 6 | Issue: 4 | Pages: 167

10.3988/jcn.2010.6.4.167 | PMID 21264197 Get It

Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging
Cho, Zang‐Hee , Min, Hoon‐Ki , Oh, Se‐Hong , Han, Jae-Yong, Park, Chan-Woong, Chi, Je-Geun, Kim, Young-Bo , Paek, Sun Ha , Lozano, Andrés M. , Lee, Kendall H. , Min, Hoon-Ki Paul

Mayo Clinic

Journal of Neurosurgery | April 9, 2010 | Volume: 113 | Issue: 3 | Pages: 639-647

10.3171/2010.3.jns091385 | PMID 20380532 Get It

Object A challenge associated with deep brain stimulation (DBS) in treating advanced Parkinson disease (PD) is the direct visualization of brain nuclei, which often involves indirect approximations of stereotactic targets. In the present study, the authors compared T2*-weighted images obtained using 7-T MR imaging with those obtained using 1.5- and 3-T MR imaging to ascertain whether 7-T imaging enables better visualization of targets for DBS in PD. Methods The authors compared 1.5-, 3-, and 7-T MR images obtained in 11 healthy volunteers and 1 patient with PD. Results With 7-T imaging, distinct images of the brain were obtained, including the subthalamic nucleus (STN) and internal globus pallidus (GPi). Compared with the 1.5- and 3-T MR images of the STN and GPi, the 7-T MR images showed marked improvements in spatial resolution, tissue contrast, and signal-to-noise ratio. Conclusions Data in this study reveal the superiority of 7-T MR imaging for visualizing structures targeted for DBS in the management of PD. This finding suggests that by enabling the direct visualization of neural structures of interest, 7-T MR imaging could be a valuable aid in neurosurgical procedures.
Planimetric Measurement of the Regurgitant Orifice Area Using Multidetector CT for Aortic Regurgitation: a Comparison with the Use of Echocardiography
Jeon, Min Hee, Park, Seung Woo , Park, Pyo Won , Oh, Jae K. , Choe, Yeon Hyeon , Cho, Soo Jin

Mayo Clinic

Korean Journal of Radiology | February 24, 2010 | Volume: 11 | Issue: 2 | Pages: 169

10.3348/kjr.2010.11.2.169 | PMID 20191064 Get It

Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Nagaraj, Srinivas, Schrum, Adam G. , Cho, Hyun-Il, Cho, Hyun-Il , Celis, Esteban , Gabrilovich, Dmitry I. , Schrum, Adam G

Mayo Clinic

The Journal of Immunology | February 8, 2010 | Volume: 184 | Issue: 6 | Pages: 3106-3116

10.4049/jimmunol.0902661 | PMID 20142361 Get It

Abstract Ag-specific T cell tolerance plays a critical role in tumor escape. Recent studies implicated myeloid-derived suppressor cells (MDSCs) in the induction of CD8+ T cell tolerance in tumor-bearing hosts. However, the mechanism of this phenomenon remained unclear. We have found that incubation of Ag-specific CD8+ T cells, with peptide-loaded MDSCs, did not induce signaling downstream of TCR. However, it prevented subsequent signaling from peptide-loaded dendritic cells. Using double TCR transgenic CD8+ T cells, we have demonstrated that MDSC induced tolerance to only the peptide, which was presented by MDSCs. T cell response to the peptide specific to the other TCR was not affected. Incubation of MDSCs with Ag-specific CD8+ T cells caused nitration of the molecules on the surface of CD8+ T cells, localized to the site of physical interaction between MDSC and T cells, which involves preferentially only TCR specific for the peptide presented by MDSCs. Postincubation with MDSCs, only nitrotyrosine-positive CD8+ T cells demonstrated profound nonresponsiveness to the specific peptide, whereas nitrotyrosine-negative CD8+ T cells responded normally to that stimulation. MDSCs caused dissociation between TCR and CD3ζ molecules, disrupting TCR complexes on T cells. Thus, these data describe a novel mechanism of Ag-specific CD8+ T cell tolerance in cancer.
Notch Regulates Cytolytic Effector Function in CD8+ T Cells
Cho, Ok Hyun, Shin, Hyun Mu , Miele, Lucio , Golde, Todd E. , Fauq, Abdul H. , Minter, Lisa M. , Osborne, Barbara A.

Mayo Clinic

The Journal of Immunology | March 5, 2009 | Volume: 182 | Issue: 6 | Pages: 3380-3389

10.4049/jimmunol.0802598 | PMID 19265115 Get It

Abstract The maturation of naive CD8+ T cells into effector CTLs is a critical feature of a functional adaptive immune system. Development of CTLs depends, in part, upon the expression of the transcriptional regulator eomesodermin (EOMES), which is thought to regulate expression of two key effector molecules, perforin and granzyme B. Although EOMES is important for effector CTL development, the precise mechanisms regulating CD8+ effector cell maturation remains poorly understood. In this study, we show that Notch1 regulates the expression of EOMES, perforin, and granzyme B through direct binding to the promoters of these crucial effector molecules. By abrogating Notch signaling, both biochemically as well as genetically, we conclude that Notch activity mediates CTL activity through direct regulation of EOMES, perforin, and granzyme B.
Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial
Cho, Nancy L. , Redston, Mark , Carothers, Adelaide M., Hornick, Jason L. , Wilton, Andrew S. , Sontag, Stephen J. , Nishioka, Norman S., Giardiello, Francis M., Saltzman, John R. , Gostout, Chris, Eagle, Craig, Hawk, Ernest T. , Zauber, Ann Graham , Bertagnolli, Monica M. , Hornick, Jason L

Mayo Clinic

Cancer Prevention Research | April 14, 2008 | Volume: 1 | Issue: 1 | Pages: 21-31

10.1158/1940-6207.capr-07-0011 | PMID 19138933 Get It

Abstract Aberrant crypt foci (ACF) are the earliest visible neoplastic lesions in the colorectum. The natural history of these lesions and their role in the adenoma-carcinoma sequence are unknown. We studied ACF in a subset of patients randomized to placebo (n = 17), celecoxib (200 mg twice daily; n = 15), or celecoxib (400 mg twice daily; n = 13) in the Adenoma Prevention with Celecoxib (APC) trial. Magnification chromoendoscopy was done to identify, count, and biopsy ACF within the rectum at baseline and after 8 to 12 months of treatment. A total of 655 ACF were identified in 45 patients. We examined 70 of these ACF histologically, and all 70 were nondysplastic. Cohort characteristics and APC trial treatment results for substudy patients were similar to those of the overall APC trial. There was no significant modulation of ACF by celecoxib (versus placebo; P = 0.77). Immunohistochemical comparison of ACF with adjacent normal mucosa showed that ACF had an increased proliferative index as determined by Ki-67 (P < 0.0001), but lacked other features of neoplasia such as increased cyclooxygenase-2 expression and microvessel density, nuclear localization of β-catenin, or decreased expression of the tumor suppressors SMAD4, Estrogen Receptor α, or MGMT. Only baseline SMAD4 expression in ACF correlated with posttreatment adenoma recurrence (independent of treatment arm; P = 0.01). The presence or number of nondysplastic ACF did not correlate with a higher risk of synchronous advanced or recurrent adenomas. Our overall results indicated that nondysplastic ACF were not accurate surrogate endpoint biomarkers of recurrent colorectal adenomas in the APC trial.
Nuclear Factor of Activated T3 Is a Negative Regulator of Ras-JNK1/2-AP-1–Induced Cell Transformation
Yao, Ke , Cho, Yong‐Yeon , Bergen, H. Robert, Ma, Weiya, Bode, Ann M. , Madden, Benjamin J. , Choi, Bu Young , Dong, Zigang

Mayo Clinic

Cancer Research | September 17, 2007 | Volume: 67 | Issue: 18 | Pages: 8725-8735

10.1158/0008-5472.can-06-4788 | PMID 17875713 Get It

Abstract The c-jun-NH2-kinases (JNK) play a critical role in tumor promoter–induced cell transformation and apoptosis. Here, we showed that the nuclear factor of activated T3 (NFAT3) is phosphorylated by JNK1 or JNK2 at Ser213 and Ser217, which are located in the conserved SP motif. The transactivation domain of NFAT3 is found between amino acids (aa) 113 and 260 and includes the phosphorylation targets of JNK1 and JNK2. NFAT3 transactivation activity was suppressed in JNK1−/− or JNK2−/− mouse embryonic fibroblast (MEF) cells compared with wild-type MEF cells. Moreover, a 3xNFAT-luc reporter gene assay indicated that NFAT3 transcriptional activity was increased in a dose-dependent manner by JNK1 or JNK2. Double mutations at Ser213 and Ser217 suppressed NFAT3 transactivation activity; and SP600125, a JNK inhibitor, suppressed NFAT3-induced 3xNFAT-luciferase activity. Knockdown of JNK1 or JNK2 suppressed foci formation in NIH3T3 cells. Importantly, ectopic expression of NFAT3 inhibited AP-1 activity and suppressed foci formation. Furthermore, knockdown of NFAT3 enhanced Ras-JNK1 or JNK2-induced foci formation in NIH3T3 cells. Taken together, these results provided direct evidence for the anti-oncogenic potential of the NFAT3 transcription factor. [Cancer Res 2007;67(18):8725–35]
Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B.
Swanson, S, Born, Teresa L., Zydowsky, Lynne D., Cho, H, Chang, Howard Y. , Rusnak, Frank, Walsh, C.T.

Mayo Clinic

Proceedings of the National Academy of Sciences | May 31, 2006 | Volume: 89 | Issue: 9 | Pages: 3741-3745

10.1073/pnas.89.9.3741 | PMID 1315036 Get It

The Ca(2+)- and calmodulin-dependent protein phosphatase calcineurin is inhibited by the immunosuppressant drug cyclosporin A in the presence of cyclophilin A or B. Of the two isoforms, cyclophilin B is more potent by a factor of 2-5 when either the phosphoprotein [32P]casein or the [32P]phosphoserine [Ser(32P)] form of the 19-residue bovine cardiac cAMP-dependent protein kinase regulatory subunit peptide RII, [Ser(32P)15]RII, is used as substrate. With [Ser(32P15]RII as substrate, the concentrations of the cyclosporin A.cyclophilin A and cyclosporin A.cyclophilin B complexes, which cause 50% inhibition of calcineurin activity, are 120 and 50 nM, respectively. Lowering the concentration of calcineurin 80% with [32P]casein as substrate lowered the apparent inhibition constant for each complex even further; 50% inhibition of calcineurin was observed at 40 nM for cyclosporin A.cyclophilin A, whereas it was less than 10 nM for cyclosporin A.cyclophilin B. In all inhibition assays with [32P]casein or [Ser(32P)15]RII, the concentration of calcineurin required for measurable phosphatase activity is such that these complexes behave as tight-binding inhibitors of calcineurin, and steady-state kinetics cannot be used to assess inhibition patterns or Ki values. Limited trypsinization of calcineurin produces a fragment that is still inhibited, indicating that the interaction of cyclosporin.cyclophilin with calcineurin does not require either calmodulin or Ca2+.
Tumors Associated With Oncogenic Osteomalacia Express Genes Important in Bone and Mineral Metabolism
Finnegan, Richard B., Vassiliadis, John, Cook, Brian P., Barberio, Dana , Estes, Scott , Manavalan, Partha, Petroziello, Joseph M., Madden, Stephen L., Cho, Justin Y., Kumar, Rajiv , Levine, Michael A. , Schiavi, Susan C., Beur, Suzanne M. Jan de , Madden, Stephen L., Kumar, Rajiv , Levine, M A

Mayo Clinic

Journal of Bone and Mineral Research | April 26, 2006 | Volume: 17 | Issue: 6 | Pages: 1102-1110

10.1359/jbmr.2002.17.6.1102 | PMID 12054166 Get It

Abstract Oncogenic osteomalacia (OOM) is associated with primitive mesenchymal tumors that secrete phosphaturic factors resulting in low serum concentrations of phosphate and calcitriol, phosphaturia, and defective bone mineralization. To identify overexpressed genes in these tumors, we compared gene expression profiles of tumors resected from patients with OOM and histologically similar control tumors using serial analysis of gene expression (SAGE). Three hundred and sixty-four genes were expressed at least twofold greater in OOM tumors compared with control tumors. A subset of 67 highly expressed genes underwent validation with an extended set of OOM and control tumors using array analysis or reverse-transcription polymerase chain reaction (RT-PCR). Ten of these validated genes were consistently overexpressed in all OOM tumors relative to control tumors. Strikingly, genes with roles in bone matrix formation, mineral ion transport, and bone mineralization were highly expressed in the OOM tumors.